Sign In
Section Navigation
Common TitleSELECT
Official Title Multicenter Study of Options for Second-Line Effective Combination Therapy (SELECT)
Phase Phase III
ClinicalTrials.gov NCT01352715
Categories Resistance/Virological FailureTreatment-ExperiencedDual Therapy
Funding
Non-IndustryNational Institute of Allergy and Infectious Diseases (NIAID)
References
  • La Rosa AM, Harrison LJ, Taiwo B, et al. Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study. Lancet HIV. 2016;3:e247-58.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.